Cargando…

Treatment with biologics during pregnancy in patients with rheumatic diseases

Detalles Bibliográficos
Autor principal:	Förger, Frauke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2017
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442294/ https://www.ncbi.nlm.nih.gov/pubmed/28539675 http://dx.doi.org/10.5114/reum.2017.67598

Ejemplares similares

Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?
por: Förger, Frauke, et al.
Publicado: (2010)

Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients
por: van den Brandt, Stephanie, et al.
Publicado: (2017)

Vaccinations in rheumatic diseases
por: Szwejkowska, Martyna, et al.
Publicado: (2020)

Comorbidities and multimorbidity in rheumatic diseases
por: Filipowicz-Sosnowska, Anna
Publicado: (2019)

Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
por: Reid, David M.
Publicado: (2020)

Biological and Methotrexate Survival after Pregnancy in Patients With a Rheumatic Disease
por: Tahmasian, Helena, et al.
Publicado: (2022)

Rheumatic and oncological diseases – common challenges
por: Jeziorski, Krzysztof
Publicado: (2017)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Panta rhei in diagnosing rheumatic diseases
por: Wiland, Piotr
Publicado: (2019)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient
por: Mojs, Ewa, et al.
Publicado: (2018)

Airway management for general anesthesia in patients with rheumatic diseases – new possibilities
por: Gaszyński, Tomasz
Publicado: (2019)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Spine and Rheumatic Diseases
por: Wei, James Cheng-Chung, et al.
Publicado: (2015)

Neuroimaging in rheumatic diseases
por: Santos, Alair Sarmet
Publicado: (2018)

Microangiopathy in Rheumatic Diseases
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

Position of magnetic resonance in the imaging of inflammatory rheumatic diseases
por: Korkosz, Mariusz
Publicado: (2015)

Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road
por: Beltagy, Asmaa, et al.
Publicado: (2021)

The role of stress in rheumatic diseases
por: Hassett, Afton L, et al.
Publicado: (2010)

The Assessment of Disease Activity in Rheumatic Diseases
por: Arayssi, Thurayya, et al.
Publicado: (2013)

Diclofenac in the treatment of pain in patients with rheumatic diseases
por: Kołodziejska, Justyna, et al.
Publicado: (2018)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases
por: Geri, Guillaume, et al.
Publicado: (2011)

Rheumatic Heart Disease in Pregnancy
por: McKeown, Florence
Publicado: (1950)

Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases
por: Schulze-Koops, Hendrik
Publicado: (2017)

POOR ADHERENCE TO DRUG TREATMENT IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE RHEUMATIC DISEASES
por: Silva, Clovis Artur
Publicado: (2019)

Risk Factors Associated with Estimated Glomerular Filtration Rate in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis after Treatment with Biological Disease Modifying Anti-Rheumatic Drugs
por: Lee, Sung Won
Publicado: (2018)

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases
por: Boyadzhieva, Vladimira Vasileva, et al.
Publicado: (2020)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases
por: Ahn, Soo Min, et al.
Publicado: (2023)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Inferring causality in biological oscillators
por: Tyler, Jonathan, et al.
Publicado: (2021)

Rain and Rheumatism
Publicado: (1880)

Gout: will the “King of Diseases” be the first rheumatic disease to be cured?
por: Singh, Jasvinder A.
Publicado: (2016)

Predictors of mortality in chronic rheumatic heart disease
por: Talwar, K. K., et al.
Publicado: (2016)

Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy
por: El Miedany, Yasser, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cobr9mipbalv90e3mf58nea1k8